Streetbeat News

Stock Prices

AKTS

BNED

WOOF

XP

Shares of XP Inc. (NASDAQ:XP) fell sharply by around 12% after reporting worse-than-expected first-quarter EPS results. XP posted earnings of 37 cents per share, missing estimates of 40 cents per share, but reported higher-than-expected sales of $818.79 million. Other stocks moving significantly include Akoustis Technologies, Inc. (NASDAQ:AKTS), Barnes & Noble Education, Inc. (NYSE:BNED), and Petco Health and Wellness Company, Inc. (NASDAQ:WOOF).

Portfolio Pulse from Avi Kapoor

May 22, 2024 | 5:28 pm

NCLH

BofA Securities analyst Andrew G. Didora reiterated a Neutral rating on Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) with a price target of $20.00. The company raised its full-year 2024 guidance and introduced new 2026 targets. Despite the positive guidance, NCLH shares are trading lower by 3.43% at $16.35.

Portfolio Pulse from Shivani Kumaresan

May 22, 2024 | 5:26 pm

BMY

SNY

A Hawaii court has ordered Bristol Myers Squibb (NYSE:BMY) and Sanofi (NASDAQ:SNY) to pay over $916 million for failing to warn non-white patients about health risks associated with their blood thinner Plavix. This ruling increases the liability from an earlier $834 million judgment. The companies plan to appeal the decision.

Portfolio Pulse from Vandana Singh

May 22, 2024 | 5:25 pm

AFRM

SQ

Shares of buy now pay later companies are trading lower due to reports that the CFPB will require them to have the same customer protections as credit card users.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 5:24 pm

PBR

Petrobras shares have resumed trading after a temporary halt. The resumption of trading could lead to increased volatility in the short term as investors react to the latest developments.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 5:21 pm

NVO

Novo Nordisk's once-weekly insulin icodec faces scrutiny from the FDA due to increased risk of low blood sugar in type 1 diabetes patients. The FDA's review has been extended by three months, with a decision expected in Q3 2024. Novo Nordisk has proposed labeling to mitigate risks.

Portfolio Pulse from Vandana Singh

May 22, 2024 | 5:21 pm

SNY

Sanofi's Phase 2 study results for Rilzabrutinib show potential as the first advanced oral treatment for moderate-to-severe asthma. The data indicates a reduction in loss of asthma control events, improvement in symptoms, and good tolerance with no new safety signals. These results support further development into a Phase 3 program.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 5:16 pm

VFS

VinFast shares are trading lower due to ongoing concerns following reports of a US regulator investigation into a crash involving a VF 8 vehicle.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 5:15 pm

CSIQ

ENPH

FSLR

SEDG

Shares of solar stocks are trading higher following President Biden's decision to raise tariffs on Chinese solar cells.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 5:12 pm

ADI

LSCC

MCHP

NVDA

ON

STM

Shares of semiconductor and chip stocks are trading higher ahead of NVIDIA's earnings report. Additionally, strong quarterly earnings from Analog Devices are contributing to the sector's positive performance.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 5:08 pm